AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 117 filers reported holding AUDENTES THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $50,064,000 | +4451.3% | 836,641 | +2038.1% | 0.01% | – |
| Q3 2019 | $1,100,000 | -65.9% | 39,131 | -54.1% | 0.00% | – |
| Q2 2019 | $3,226,000 | -15.5% | 85,182 | -12.9% | 0.00% | -100.0% |
| Q1 2019 | $3,816,000 | +412.9% | 97,808 | +180.0% | 0.00% | – |
| Q4 2018 | $744,000 | -60.5% | 34,926 | -26.6% | 0.00% | – |
| Q3 2018 | $1,882,000 | -1.8% | 47,555 | -5.2% | 0.00% | – |
| Q2 2018 | $1,917,000 | +42.4% | 50,147 | +12.0% | 0.00% | – |
| Q1 2018 | $1,346,000 | +10.0% | 44,791 | +14.3% | 0.00% | – |
| Q4 2017 | $1,224,000 | +38.8% | 39,184 | +24.5% | 0.00% | – |
| Q3 2017 | $882,000 | +61.5% | 31,472 | +10.4% | 0.00% | – |
| Q2 2017 | $546,000 | +36.8% | 28,496 | +21.8% | 0.00% | – |
| Q1 2017 | $399,000 | +14.7% | 23,399 | +22.6% | 0.00% | – |
| Q4 2016 | $348,000 | -2.8% | 19,089 | -5.1% | 0.00% | – |
| Q3 2016 | $358,000 | – | 20,106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 767,502 | $45,927,000 | 23.65% |
| Chicago Capital Management, LLC | 250,401 | $14,984,000 | 12.57% |
| Foresite Capital Management III, LLC | 233,067 | $13,947,000 | 7.82% |
| Partner Investment Management, L.P. | 17,795 | $1,065,000 | 7.65% |
| RAMIUS ADVISORS LLC | 220,784 | $13,212,000 | 5.68% |
| Beryl Capital Management LLC | 550,426 | $32,937,000 | 5.31% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 647,460 | $38,744,000 | 5.28% |
| FNY Investment Advisers, LLC | 278,861 | $16,687,000 | 5.17% |
| WHITE SQUARE CAPITAL LLP | 112,500 | $6,732,000 | 4.87% |
| Casdin Capital, LLC | 860,000 | $51,462,000 | 4.73% |